会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 122. 发明授权
    • Triazine carboxylic acids and esters
    • 三嗪羧酸和酯
    • US5021415A
    • 1991-06-04
    • US479563
    • 1990-02-13
    • Nicholas A. Meanwell
    • Nicholas A. Meanwell
    • C07D253/04C07D253/07
    • C07D253/04C07D253/07
    • Heterocyclic acids and esters useful as inhibitors of mammalian blood platelet aggregation characterized by Formula I or II are disclosed. ##STR1## Formula I compounds are those wherein n is 6-9, R is hydrogen, lower alkyl or an alkali metal ion, and HET.sub.1 is the heterocyclic radical 2,3-dihydro-3-oxo-5,6-diphenyl-1,2,4-triazin-2-yl.Formula II compounds are those wherein R.sub.1 is hydrogen, lower alkyl or an alkali metal ion, and the radical --OCH.sub.2 CO.sub.2 R is attached in the 3 or 4 ring position; and HET.sub.2 is the heterocyclic radical 2,3-dihydro-3-oxo-5,6-diphenylmethyl-1,2,3-triazin-2-yl.
    • 公开了用作哺乳动物血小板聚集体抑制剂的杂环酸和酯,其特征在于式I或II。 (II)式I化合物是其中n为6-9,R为氢,低级烷基或碱金属离子的化合物,HET1为杂环基2,3-二氢 - 3-氧代-5,6-二苯基-1,2,4-三嗪-2-基。 式II化合物是其中R 1是氢,低级烷基或碱金属离子并且基团-OCH 2 CO 2 R连接在3或4环位置的化合物; HET2是杂环基2,3-二氢-3-氧代-5,6-二苯基甲基-1,2,3-三嗪-2-基。
    • 124. 发明授权
    • Imidazole carboxylic acids and esters and inhibition of blood platelet
aggregation therewith
    • 咪唑羧酸和酯类,抑制血小板聚集
    • US5011851A
    • 1991-04-30
    • US540988
    • 1990-06-20
    • Nicholas A. Meanwell
    • Nicholas A. Meanwell
    • C07D233/54C07D233/64C07D233/84
    • C07D233/64C07D233/84
    • Heterocyclic acids and esters useful as inhibitors of mammalian blood platelet aggregation characterized by Formula I or II are disclosed.HET.sub.1 --(CH.sub.2).sub.n CO.sub.2 R (I) ##STR1## Formula I compounds are those wherein n is 6-9, R is hydrogen, lower alkyl or an alkali metal ion, and HET.sub.1 is the heterocyclic radical 4,5-diphenyl-1H-imidazol-2-yl.Formula II compounds are those wherein R.sub.1 is hydrogen, lower alkyl or an alkali metal ion, and the radical --OCH.sub.2 CO.sub.2 R is attached in the 3 or 4 ring position; and HET.sub.2 is the heterocyclic radical 4,5-diphenyl-1H-imidazol-2-yl.Formula VIII compounds are those wherein R.sub.1 is hydrogen, lower alkyl or an alkali metal ion, and the radical --OCH.sub.2 CO.sub.2 R is attached in the 3 or 4 ring position.
    • 公开了用作哺乳动物血小板聚集体抑制剂的杂环酸和酯,其特征在于式I或II。 (VIII)式Ⅰ化合物是其中n为6-9的化合物,R为氢,低级烷基或碱金属离子,HET1为杂环基 自由基4,5-二苯基-1H-咪唑-2-基。 式II化合物是其中R 1是氢,低级烷基或碱金属离子并且基团-OCH 2 CO 2 R连接在3或4环位置的化合物; HET2是杂环基4,5-二苯基-1H-咪唑-2-基。 式VIII化合物是其中R 1是氢,低级烷基或碱金属离子,基团-OCH 2 CO 2 R连接在3或4个环位的那些。